| Application no. and date | 21174262.2 (espacenet) (Federated) (European Patent Register), 20180629 | | Patent/reg. no. and date | DK/EP 3925950, 20230906 | | Publication date | 20211222 | | Priority no. and date | US 201762527174 P, 20170630, US 201862664363 P, 20180430 | | EP pub. no. and date |
EP 3925950 20211222 | | Effective date | | | Applicant/owner | Amgen Inc., One Amgen Center Drive
Thousand Oaks, CA 91320-1799, US | | Applicant ref. no. | | | Inventor | CAILLE, Sebastien,
Moorpark, US,
QUASDORF, Kyle,
Thousand Oaks, US,
ROOSEN, Philipp,
Thousand Oaks, US,
SHI, Xianqing,
Newbury Park, US,
COSBIE, Andrew,
Ventura, US,
WANG, Fang,
Simi Valley, US,
WU, Zufan,
Walnut, US,
NEERGUNDA, Archana,
Simi Valley, US,
QUAN, Peter Bin,
Woodland, US,
GUAN, Lianxiu,
Camarillo, US | | Representative | | | Opponent | | | IPC Class | C07D 213/75 (2006.01) | | Title | SYNTHESIS OF OMECAMTIV MECARBIL | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
